80
68
Growth Score
-8 pts
Heat Score
-18 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
772350
SynerK, Inc develops RNA-targeted medicines for oncology, vaccines, and rare diseases.
- Wayne Jiang: Co-Founder & VP
About the Company
SynerK, Inc develops RNA-targeted medicines focusing on oncology, vaccines, and rare diseases. The company aims to treat genetic disorders and immuno-oncology conditions by engineering life-changing therapies. SynerK's pipeline includes innovative solutions for various cancers and genetic defects, striving to improve patient outcomes one at a
time.
